Evaluation of Serum Farnesoid X Receptor (FXR) Levels and Their Correlation with Metabolic Parameters Related to Obesity: A Clinical Investigation - Scorecard - MDSpire

Evaluation of Serum Farnesoid X Receptor (FXR) Levels and Their Correlation with Metabolic Parameters Related to Obesity: A Clinical Investigation

  • By

  • Zeyneb Irem Yuksel Salduz

  • Rana Turgut

  • Zeynep Seval Coskun

  • Ozge Pasin

  • Murat Kartal

  • Aclan Ozder

  • April 15, 2026

  • 0 min

Share

Clinical Scorecard: Evaluation of Serum Farnesoid X Receptor (FXR) Levels and Their Correlation with Metabolic Parameters Related to Obesity: A Clinical Investigation

At a Glance

CategoryDetail
ConditionObesity
Key MechanismsFarnesoid X Receptor (FXR) regulates bile acid and cholesterol homeostasis, influencing glucose, lipid, and energy metabolism.
Target PopulationAdults aged 18-65 years without chronic diseases.
Care SettingFamily Medicine Clinic and Nutrition and Diet Polyclinic.

Key Highlights

  • Obesity is a major risk factor for comorbidities like Type 2 Diabetes Mellitus and cardiovascular disease.
  • FXR is critical for bile acid metabolism and may serve as a therapeutic target for obesity.
  • Higher total bile acid levels are observed in obese individuals, correlating positively with BMI.

Guideline-Based Recommendations

Diagnosis

  • Use BMI as the primary criterion for defining obesity.

Management

  • Implement medical nutrition therapy, behavioral interventions, increased physical activity, and consider pharmacological treatments.

Monitoring & Follow-up

  • Assess serum FXR levels and metabolic parameters in obese individuals.

Risks

  • Obesity is linked to increased mortality and various comorbidities.

Patient & Prescribing Data

Individuals aged 18-65 years without chronic diseases.

Further studies are needed to explore FXR modulation as a therapeutic strategy for obesity.

Clinical Best Practices

  • Monitor FXR levels in relation to BMI for potential therapeutic insights.
  • Consider the role of bile acids in obesity management.

References

Original Source(s)

Related Content